ABBOTT INDIA LIMITED
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
- Conditions
- First Posted Date
- 2003-12-04
- Last Posted Date
- 2006-08-02
- Lead Sponsor
- Abbott
- Target Recruit Count
- 30
- Registration Number
- NCT00073710
- Locations
- 🇺🇸
Creighton University, Omaha, Nebraska, United States
A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2003-11-18
- Last Posted Date
- 2007-11-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 30
- Registration Number
- NCT00073151
- Locations
- 🇺🇸
Dayton Oncology and Hematology, Kettering, Ohio, United States
🇺🇸Oncology Hematology Group of South Florida, Miami, Florida, United States
🇺🇸Oncology & Hematology Associates of Kansas City, PA, Kansas City, Missouri, United States
Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma
- Conditions
- First Posted Date
- 2003-11-18
- Last Posted Date
- 2007-08-15
- Lead Sponsor
- Abbott
- Target Recruit Count
- 103
- Registration Number
- NCT00073125
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸Virginia G. Piper Cancer Center, Scottsdale, Arizona, United States
🇺🇸UCLA School of Medicine, Los Angeles, California, United States
A Study of ABT-751 in Patients With Colorectal Cancer
- Conditions
- First Posted Date
- 2003-11-18
- Last Posted Date
- 2007-11-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 40
- Registration Number
- NCT00073138
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
🇺🇸University of Wisconsin Medical Center, Madison, Wisconsin, United States
🇺🇸University of Southern California, Los Angeles, California, United States
A Study of ABT-751 in Patients With Renal Cell Cancer
- Conditions
- First Posted Date
- 2003-11-18
- Last Posted Date
- 2007-11-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 60
- Registration Number
- NCT00073112
- Locations
- 🇺🇸
US Oncology Inc Rocky Mountain Cancer Centers, Denver, Colorado, United States
🇨🇦B.C. Vancouver Cancer Agency, Vancouver, British Columbia, Canada
🇨🇦McGill University, Montreal, Quebec, Canada
Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia
- Conditions
- First Posted Date
- 2003-11-18
- Last Posted Date
- 2006-08-04
- Lead Sponsor
- Abbott
- Target Recruit Count
- 400
- Registration Number
- NCT00073164
Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
- Conditions
- First Posted Date
- 2003-10-20
- Last Posted Date
- 2006-08-04
- Lead Sponsor
- Abbott
- Target Recruit Count
- 180
- Registration Number
- NCT00071253
- Locations
- 🇺🇸
Rush Presbyterian - St. Luke's, Chicago, Illinois, United States
🇺🇸UTMB Dept. of Psychiatry, Galveston, Texas, United States
🇺🇸University of Mississippi Medical Center, Jackson, Mississippi, United States
A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease
- Conditions
- First Posted Date
- 2003-10-02
- Last Posted Date
- 2006-09-04
- Lead Sponsor
- Abbott
- Target Recruit Count
- 64
- Registration Number
- NCT00069849
A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children
- Conditions
- First Posted Date
- 2003-08-20
- Last Posted Date
- 2006-08-04
- Lead Sponsor
- Abbott
- Target Recruit Count
- 300
- Registration Number
- NCT00067431
- Locations
- 🇺🇸
Pediatric Epilepsy & Neurology Specialist, Tampa, Florida, United States
🇺🇸Virginia Commonwealth University, Richmond, Virginia, United States
🇺🇸Rainbow Babies Children's Hospital, Cleveland, Ohio, United States
An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
- Conditions
- First Posted Date
- 2003-08-15
- Last Posted Date
- 2006-08-04
- Lead Sponsor
- Abbott
- Target Recruit Count
- 150
- Registration Number
- NCT00067262
- Locations
- 🇺🇸
Mountain West Clinical Trials, Boise, Idaho, United States
🇺🇸Professional Clinical Research, Inc., Miami, Florida, United States
🇺🇸University of Texas Medical Branch, Houston, Texas, United States